Post-infectious Irritable Bowel Syndrome

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2006 Jul 14

PMID 16836945

Citations 11

Authors

Dolores Y Rhodes

Mark Wallace

Affiliations

Soon will be listed here.

Abstract

Irritable bowel syndrome (IBS) affects 8% to 22% of the general population. Although patients describe an insidious onset of symptoms, including abdominal pain relieved with bowel movements, excessive intestinal gas, variable bowel habits, and abdominal bloating, a subgroup of individuals describe the onset of IBS symptoms following an episode of acute gastroenteritis, known as post-infectious IBS (PI-IBS). Several studies have demonstrated the development of IBS following infection. Risk factors for the development of PI-IBS are female sex and longer duration of initial illness. Although the underlying mechanism of PI-IBS is unclear, ongoing inflammation is clearly a factor in the pathogenesis. The underlying inflammatory process results in increased enterochromaffin cells, T-lymphocytes, intestinal permeability, colonic transit time, and a variety of immunologic abnormalities. PI-IBS patients tend to have a better prognosis than do those with idiopathic IBS, with resolution of symptoms within 5 to 6 years. Treatment is similar to that of idiopathic IBS.

Citing Articles

Study on the Role of Gastrointestinal Parasite in Irritable Bowel Syndrome Patients in a Tribal Region of India.

Das B, Panda A, Patra M, Nayak K Cureus. 2022; 14(6):e26091.

PMID: 35875298 PMC: 9295901. DOI: 10.7759/cureus.26091.

Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place.

Rani R, Ali R, Lee Y Intest Res. 2016; 14(4):297-304.

PMID: 27799880 PMC: 5083258. DOI: 10.5217/ir.2016.14.4.297.

Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders.

Paula H, Grover M, Halder S, Locke 3rd G, Schleck C, Zinsmeister A Neurogastroenterol Motil. 2015; 27(11):1580-6.

PMID: 26303310 PMC: 4624515. DOI: 10.1111/nmo.12655.

Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?.

Ishihara S, Aziz M, Oshima N, Mishima Y, Imaoka H, Moriyama I Clin J Gastroenterol. 2015; 2(1):9-16.

PMID: 26191801 DOI: 10.1007/s12328-008-0051-y.

Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Mansueto P, DAlcamo A, Seidita A, Carroccio A World J Gastroenterol. 2015; 21(23):7089-109.

PMID: 26109796 PMC: 4476871. DOI: 10.3748/wjg.v21.i23.7089.

References

Parry S, Stansfield R, Jelley D, Gregory W, Phillips E, Barton J . Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol. 2003; 98(9):1970-5. DOI: 10.1111/j.1572-0241.2003.07664.x. View

Swain M, Blennerhassett P, Collins S . Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology. 1991; 100(3):675-82. DOI: 10.1016/0016-5085(91)80011-w. View

Neal K, Barker L, Spiller R . Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002; 51(3):410-3. PMC: 1773359. DOI: 10.1136/gut.51.3.410. View

Gwee K, GRAHAM J, McKendrick M, Collins S, Marshall J, Walters S . Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 1996; 347(8995):150-3. DOI: 10.1016/s0140-6736(96)90341-4. View

Spiller R, Jenkins D, Thornley J, Hebden J, Wright T, Skinner M . Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000; 47(6):804-11. PMC: 1728147. DOI: 10.1136/gut.47.6.804. View

Harvey R, Mauad E, Brown A . Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet. 1987; 1(8539):963-5. DOI: 10.1016/s0140-6736(87)90304-7. View

King T, Elia M, Hunter J . Abnormal colonic fermentation in irritable bowel syndrome. Lancet. 1998; 352(9135):1187-9. DOI: 10.1016/s0140-6736(98)02146-1. View

Cremonini F, Talley N . Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005; 34(2):189-204. DOI: 10.1016/j.gtc.2005.02.008. View

Gonsalkorale W, Perrey C, Pravica V, Whorwell P, Hutchinson I . Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?. Gut. 2002; 52(1):91-3. PMC: 1773523. DOI: 10.1136/gut.52.1.91. View

10.

Bearcroft C, Perrett D, Farthing M . Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998; 42(1):42-6. PMC: 1726971. DOI: 10.1136/gut.42.1.42. View

11.

McKendrick M, Read N . Irritable bowel syndrome--post salmonella infection. J Infect. 1994; 29(1):1-3. DOI: 10.1016/s0163-4453(94)94871-2. View

12.

Gwee K, Collins S, Read N, Rajnakova A, Deng Y, GRAHAM J . Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003; 52(4):523-6. PMC: 1773606. DOI: 10.1136/gut.52.4.523. View

13.

Rodriguez L, Ruigomez A . Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999; 318(7183):565-6. PMC: 27756. DOI: 10.1136/bmj.318.7183.565. View

14.

Niaz S, Sandrasegaran K, Renny F, Jones B . Postinfective diarrhoea and bile acid malabsorption. J R Coll Physicians Lond. 1997; 31(1):53-6. PMC: 5420841. View

15.

Spiller R . Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004; 18(4):641-61. DOI: 10.1016/j.bpg.2004.04.002. View

16.

Gwee K, Leong Y, Graham C, McKendrick M, Collins S, Walters S . The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999; 44(3):400-6. PMC: 1727402. DOI: 10.1136/gut.44.3.400. View

17.

Neal K, Hebden J, Spiller R . Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997; 314(7083):779-82. PMC: 2126206. DOI: 10.1136/bmj.314.7083.779. View

18.

Mach T . The brain-gut axis in irritable bowel syndrome--clinical aspects. Med Sci Monit. 2004; 10(6):RA125-31. View

19.

Whitehead W, Palsson O, Jones K . Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002; 122(4):1140-56. DOI: 10.1053/gast.2002.32392. View

20.

Dunlop S, Jenkins D, Neal K, Spiller R . Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2004; 125(6):1651-9. DOI: 10.1053/j.gastro.2003.09.028. View